Good news in terms of strategy validation.
Although I am surprised with the US sales figure number of only USD$25m for 12 months to Sept 2020.
When Acrux filed to FDA in Aug 2020, the addressable market was around USD139m! Perhaps, there have been some bad news in terms of side effects for the testosterone product since that date...I'm not sure.
- Forums
- ASX - By Stock
- Ann: Acrux Receives FDA Approval - Generic Testosterone Solution
ACR
acrux limited
Add to My Watchlist
5.00%
!
1.9¢

Good news in terms of strategy validation.Although I am...
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
1.9¢ |
Change
-0.001(5.00%) |
Mkt cap ! $7.747M |
Open | High | Low | Value | Volume |
2.0¢ | 2.0¢ | 1.9¢ | $13.72K | 687.1K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
6 | 618035 | 1.9¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
2.0¢ | 10000 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
6 | 618035 | 0.019 |
3 | 381800 | 0.018 |
3 | 472000 | 0.017 |
1 | 66732 | 0.015 |
1 | 70000 | 0.014 |
Price($) | Vol. | No. |
---|---|---|
0.020 | 10000 | 1 |
0.021 | 177000 | 1 |
0.022 | 27574 | 2 |
0.023 | 115126 | 4 |
0.024 | 306848 | 8 |
Last trade - 14.19pm 18/06/2025 (20 minute delay) ? |
Featured News
ACR (ASX) Chart |
The Watchlist
MEM
MEMPHASYS LIMITED.
Professor John Aitken, Scientific Director
Professor John Aitken
Scientific Director
Previous Video
Next Video
SPONSORED BY The Market Online